The heparan sulfate mimetic PI-88 is a potent inhibitor of HIV-1 independently of its anti-heparanase activity

ANTIVIRAL RESEARCH · Published 2026-08-01 · DOI 10.1016/j.antiviral.2026.106506

Free full text

Authors (6)

Coline Seurre, Christophe Gallard, Coline Arone, Delphine Muriaux, Fabien Zoulim, Boyan Grigorov

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Seurre, C., Gallard, C., Arone, C., et al. (2026). The heparan sulfate mimetic PI-88 is a potent inhibitor of HIV-1 independently of its anti-heparanase activity. ANTIVIRAL RESEARCH. https://doi.org/10.1016/j.antiviral.2026.106506

Related articles

• Envelope protein residue E152 confers enhanced GAS6-dependent cell entry to the African Zika virus strain MR766 · ANTIVIRAL RESEARCH · 2026 · Same journal
• Recombinant polyclonal antibody GIGA-2339 potently and pan-genotypically neutralizes hepatitis B virus · ANTIVIRAL RESEARCH · 2026 · Same journal
• Fluorescence polarization–based high-throughput screening identifies SAM-competitive inhibitors of monkeypox virus N7-methyltransferase · ANTIVIRAL RESEARCH · 2026 · Same journal
• Human monoclonal antibodies from donors vaccinated with recombinant vaccinia vaccine targeting A35 and B6 effectively inhibit orthopoxvirus spread and infection · ANTIVIRAL RESEARCH · 2026 · Same journal
• Nanoparticles in viral pneumonia: diagnosis, therapy, and prevention · ANTIVIRAL RESEARCH · 2026 · Same journal
• A subset of histamine H4 receptor antagonists prevents B lymphocyte proliferation induced by BCR/TLR9 engagement or EBV infection · ANTIVIRAL RESEARCH · 2026 · Same journal
• A stapled viral peptide blocks HSV-2 from infecting human cervical cells · ANTIVIRAL RESEARCH · 2026 · Same journal
• Human cytomegalovirus terminase inhibitors letermovir, tomeglovir, and the halogenated benzimidazoles modify DNA cleavage/packaging to generate a super-genomic DNA species by cleavage site skipping · ANTIVIRAL RESEARCH · 2026 · Same journal
• Cell-type specific effects of SARS-CoV-2 P252L mutation on nirmatrelvir sensitivity · ANTIVIRAL RESEARCH · 2026 · Same journal
• Neutralizing antibodies as A therapy for hepatitis E virus: Advances, challenges and opportunities · ANTIVIRAL RESEARCH · 2026 · Same journal